Purpose

The objective of this study is to evaluate the safety and performance of the Solo+ Tympanostomy Tube Device for the placement of tympanostomy tubes (grommets) in paediatric patients undergoing a tympanostomy procedure

Conditions

Eligibility

Eligible Ages
Between 6 Months and 15 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Listed for bilateral tympanostomy tube insertion

Exclusion Criteria

  • Anatomy that precludes sufficient visualisation of both the left and right eardrum - Narrow ear canals - Anatomy that precludes safe access to both the left and right eardrum - Membrane >25% sclerosis - Congenital or craniofacial abnormalities - No available baseline audiometry and tympanometry

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Solo+ Tympanostomy Tube Device
The Solo+ Tympanostomy Tube Device is a disposable surgical tool designed to deliver a tympanostomy tube (grommet) into the tympanic membrane of patients undergoing a tympanostomy tube placement procedure
  • Device: Solo+ Tympanostomy Tube Device
    The Solo+ Tympanostomy Tube Device is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure

Recruiting Locations

More Details

NCT ID
NCT04148417
Status
Active, not recruiting
Sponsor
AventaMed DAC

Detailed Description

The study will be a multi-site, prospective, treatment-only study of the Solo+ Tympanostomy Tube Device. Patients will already have a scheduled tympanostomy procedure.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.